Surrogate gene therapy for muscular dystrophy
An engineered truncated gene derived from the dystrophin-related protein (utrophin), prevents pathology without an immune response in an animal model of Duchenne muscular dystrophy (DMD) gene therapy.
मुख्य लेखकों: | Davies, KE, Chamberlain, JS |
---|---|
स्वरूप: | Journal article |
भाषा: | English |
प्रकाशित: |
Springer Nature
2019
|
समान संसाधन
समान संसाधन
-
Therapeutic approaches to muscular dystrophy.
द्वारा: Goyenvalle, A, और अन्य
प्रकाशित: (2011) -
The Pathogenesis and Therapy of Muscular Dystrophies
द्वारा: Guiraud, S, और अन्य
प्रकाशित: (2015) -
Progress in therapy for Duchenne muscular dystrophy.
द्वारा: Fairclough, R, और अन्य
प्रकाशित: (2011) -
Progress in therapy for Duchenne muscular dystrophy
द्वारा: Fairclough, R, और अन्य
प्रकाशित: (2011) -
Utrophin in the therapy of Duchenne Muscular Dystrophy
द्वारा: Potter, A, और अन्य
प्रकाशित: (2006)